A - Human Necessities – 61 – N
Patent
A - Human Necessities
61
N
167/101, 358/23
A61N 5/00 (2006.01) A61K 41/00 (2006.01) A61K 51/12 (2006.01) A61N 5/10 (2006.01)
Patent
CA 1288693
A B S T R A C T Frequency selective radiation therapy providing selective tissue damage or necrosis by irradiating a component element of the target tissue at the corresponding Mossbauer absorption frequency. The component radiation absorption at the Mossbauer absorption frequency is thus enhanced many times over the absorption of the surrounding tissue having a different Mossbauer absorption frequency. The energy thusly absorbed by the target tissue component is converted to and remitted as Auger electrons, which provide intranuclear radiation resulting in lethal double strand breaks in the DNA molecules of the target tissue. The therapy is administered in frequency and tissue selective modes of treatment, and may be combined with conventional chemotherapeutic agents to provide a further enhanced treatment modality. Moreover, the source frequency can be adjusted to enhance the killing effect. The therapy method and apparatus according to the present invention is useful in combination with naturally occuring or administered pharamceutical stable isotope absorbers, having significantly reduced side effects by comparison to conventional chemotherapy or radiation therapy.
503616
French David J.
Mills Randell L.
LandOfFree
Mossbauer cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mossbauer cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mossbauer cancer therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1226827